BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32065282)

  • 1. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.
    Lecouvet FE; Pasoglou V; Van Nieuwenhove S; Van Haver T; de Broqueville Q; Denolin V; Triqueneaux P; Tombal B; Michoux N
    Eur Radiol; 2020 Jun; 30(6):3083-3093. PubMed ID: 32065282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.
    Johnston EW; Latifoltojar A; Sidhu HS; Ramachandran N; Sokolska M; Bainbridge A; Moore C; Ahmed HU; Punwani S
    Eur Radiol; 2019 Jun; 29(6):3159-3169. PubMed ID: 30519933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MRI in oncology: can a single anatomic T2 Dixon sequence replace the combination of T1 and STIR sequences to detect skeletal metastasis and myeloma?
    Chiabai O; Van Nieuwenhove S; Vekemans MC; Tombal B; Peeters F; Wuts J; Triqueneaux P; Omoumi P; Kirchgesner T; Michoux N; Lecouvet FE
    Eur Radiol; 2023 Jan; 33(1):244-257. PubMed ID: 35925384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
    Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
    Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A; Omoumi P; Pasoglou V; Michoux N; Triqueneaux P; Tombal B; Cyteval C; Lecouvet FE
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
    Metser U; Chan R; Veit-Haibach P; Ghai S; Tau N
    AJR Am J Roentgenol; 2019 Feb; 212(2):377-381. PubMed ID: 30332285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the fast spin-echo three-point Dixon (mDixon) image of the knee joint on 3.0-T MRI: comparison with conventional fast spin-echo T2 weighted image.
    Park HJ; Lee SY; Rho MH; Chung EC; Ahn JH; Park JH; Lee IS
    Br J Radiol; 2016 Jun; 89(1062):20151074. PubMed ID: 27008281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fat suppression in T1 and T2 FSE with mDixon superior to the frequency selection-based SPAIR technique in musculoskeletal tumor imaging?
    Huijgen WHF; van Rijswijk CSP; Bloem JL
    Skeletal Radiol; 2019 Dec; 48(12):1905-1914. PubMed ID: 31154494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American College of Radiology-Compliant Short Protocol Breast MRI for High-Risk Breast Cancer Screening: A Prospective Feasibility Study.
    Dogan BE; Scoggins ME; Son JB; Wei W; Candelaria R; Yang WT; Ma J
    AJR Am J Roentgenol; 2018 Jan; 210(1):214-221. PubMed ID: 29091003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.
    Li C; Liu ZS; Du XM; He L; Chen J; Wang W; Sun F; Du F; Luo ZG; Xue ZL; Zhao Y; Zhou CW
    Chin Med Sci J; 2009 Jun; 24(2):112-6. PubMed ID: 19618609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between 2D FSE T2-weighted Dixon MRI and contrast-enhanced 2D FSE and 3D FSPGR T1-weighted Dixon MRI to quantify inflammation in hands of patients with early rheumatoid arthritis.
    Dion B; Lacrosse R; Michoux N; Stoenoiu M; Durez P; Lecouvet F; Kirchgesner T
    Diagn Interv Imaging; 2023; 104(7-8):351-358. PubMed ID: 36997374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
    Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
    Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conspicuity of bone metastases on fast Dixon-based multisequence whole-body MRI: clinical utility per sequence.
    Costelloe CM; Madewell JE; Kundra V; Harrell RK; Bassett RL; Ma J
    Magn Reson Imaging; 2013 Jun; 31(5):669-75. PubMed ID: 23290478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
    De Vuysere S; Vandecaveye V; De Bruecker Y; Carton S; Vermeiren K; Tollens T; De Keyzer F; Dresen RC
    BMC Med Imaging; 2021 Feb; 21(1):18. PubMed ID: 33546626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
    Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
    Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
    Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
    J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Acceleration Three-Dimensional T1-Weighted Dual Echo Dixon Hepatobiliary Phase Imaging Using Compressed Sensing-Sensitivity Encoding: Comparison of Image Quality and Solid Lesion Detectability with the Standard T1-Weighted Sequence.
    Nam JG; Lee JM; Lee SM; Kang HJ; Lee ES; Hur BY; Yoon JH; Kim E; Doneva M
    Korean J Radiol; 2019 Mar; 20(3):438-448. PubMed ID: 30799575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR evaluation of vertebral metastases: T1-weighted, short-inversion-time inversion recovery, fast spin-echo, and inversion-recovery fast spin-echo sequences.
    Mehta RC; Marks MP; Hinks RS; Glover GH; Enzmann DR
    AJNR Am J Neuroradiol; 1995 Feb; 16(2):281-8. PubMed ID: 7726074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.